MedPath

Rimantadine Hydrochloride

Rimantadine Hydrochloride Tablets, USP (100 mg) Rx Only

Approved
Approval ID

49f7d69a-820b-4c75-a31d-b2104c019c12

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 31, 2023

Manufacturers
FDA

Amneal Pharmaceuticals of New York LLC

DUNS: 123797875

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Rimantadine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0115-1911
Application NumberANDA076132
Product Classification
M
Marketing Category
C73584
G
Generic Name
Rimantadine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 31, 2023
FDA Product Classification

INGREDIENTS (7)

HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
RIMANTADINE HYDROCHLORIDEActive
Quantity: 100 mg in 1 1
Code: JEI07OOS8Y
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rimantadine Hydrochloride - FDA Drug Approval Details